Assignee
EVESTRA INC
US·7 granted patents·9 pending applications·59 citations·filing 2009–2022
Top patents by PatentIndex Score
16 records- 0191US7960368B2Bismethylene-17A carbolactones and related usesEVESTRA INC·Filed 2009·Granted Jun 14, 2011·53 cites·25 claims
- 0276US10273263B2Pro-drug forming compoundsEVESTRA INC·Filed 2017·Granted Apr 30, 2019·2 cites·18 claims
- 0374US10053485B2Cytotoxic agents that preferentially target leukemia inhibitory factor (LIF) for the treatment of malignancies and as new contraceptive agentsEVESTRA INC·Filed 2016·Granted Aug 21, 2018·2 cites·5 claims
- 0472US9745338B2Pro-drug forming compoundsEVESTRA INC·Filed 2014·Granted Aug 29, 2017·2 cites·11 claims
- 0568US2019328656A1Targeted delivery of progestins and estrogens via vaginal ring devices for fertility control and hrt productsEVESTRA INC·Filed 2019·Application pending·0 cites
- 0668US2019328657A1Hormonal contraception using a vaginal ring which releases estriolEVESTRA INC·Filed 2019·Application pending·0 cites
- 0768US2019328658A1Estrogen prodrugs and methods of administering estrogen prodrugsEVESTRA INC·Filed 2019·Application pending·0 cites
- 0865US10738075B2Cytotoxic agents that preferentially target leukemia inhibitory factor (LIF) for the treatment of malignancies and as new contraceptive agentsEVESTRA INC·Filed 2018·Granted Aug 11, 2020·0 cites·9 claims
- 0956US10624903B2Longer-acting progestin prodrug contraceptivesEVESTRA INC·Filed 2018·Granted Apr 21, 2020·0 cites·14 claims
- 1055US2020237656A1Drug device combination for the effective treatment of incontinence in womenEVESTRA INC·Filed 2019·Application pending·0 cites
- 1153US9850273B2Combination of estrogens plus antiprogestins with significant partial agonistic effect as an effective treatment of menopausal symptoms and for prevention of the occurrence of breast cancerEVESTRA INC·Filed 2015·Granted Dec 26, 2017·0 cites·13 claims
- 1253US2024124515A1Orally active leukemia inhibitory factor (lif) antagonists for the treatment of cancerEVESTRA INC·Filed 2022·Application pending·0 cites
- 1352US2020383906A1Hormonal contraception using a vaginal ring which releases estriol and trimegestoneEVESTRA INC·Filed 2020·Application pending·0 cites
- 1448US2020087340A1Lif/lifr antagonist in oncology and nonmalignant diseasesEVESTRA INC·Filed 2019·Application pending·0 cites
- 1546US2018155386A1Progesterone antagonistsEVESTRA INC·Filed 2017·Application pending·0 cites
- 1644US2017319833A1Intravaginal drug delivery deviceEVESTRA INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when EVESTRA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →